ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Erythropoietin Reduces Alloantibody Formation by Inhibiting T Follicular Helper Cells

C. Cantarelli1, C. Guglielmo2, S. Bin2, A. Cumpelik2, C. Donadei3, L. Anderson4, S. Hartzell2, K. Budge2, M. Haverly2, A. Angeletti3, G. La Manna3, E. Fiaccadori1, U. Maggiore1, P. Heeger2, P. Cravedi2

1Parma University, Parma, Italy, 2Icahn School of Medicine at Mount Sinai, New York, NY, 3St. Orsola Hospital University of Bologna, Bologna, Italy, 4Icahn School of Medicine, New York, NY

Meeting: 2020 American Transplant Congress

Abstract number: D-321

Keywords: Alloantibodies, B cells

Session Information

Session Name: Poster Session D: B-cell / Antibody /Autoimmunity

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Donor-specific antibodies (DSA) develop in a significant minority of transplant recipients and are associated with increased morbidity and mortality, underscoring the need to identify approaches to prevent DSA formation. Building upon previous work showing that erythropoietin (EPO) directly inhibits effector T cells, we tested the hypothesis that EPO therapy limits DSA formation by directly inhibiting B cells and/or via inhibiting T follicular helper (TFH) cells required for class switch recombination and affinity maturation.

*Methods: We quantified DSA, splenic TFH, T follicular regulatory (TFR) cells, germinal center (GC) and class switched B cells in murine recipients of allogeneic heart transplants and in parent-to-F1 models of graft versus host disease (GVHD). We immunized C57BL/6J (B6) mice with sheep red blood cells (SRBC, T-cell-dependent) or with TNP-LPS (T-cell-independent), treated them with EPO or vehicle and quantified GC B cells, TFH, T follicular regulatory cells (TFR) and specific IgG antibodies. We used newly generated EPO receptor (EPOR)fl/fl CD4-CrePOS mice (lack EPOR on T cells) and CreNEG controls to test a direct effect of EPO on TFH and DSA in murine heart transplant recipients.

*Results: In heart transplant recipients, EPO reduced DSA, TFH, GC and class switched B cells, and increased TFR (Figure 1), effects not observed in mice lacking EPOR on T cells (Figure 1). EPO similarly reduced anti-SRBC IgG and GC B cells following SRBC immunization. In contrast, EPO had no effect in TNP-LPS immunized mice, together indicating EPO’s effect on preventing antibody formation is via targeting TFH rather than directly inhibiting B cells. In two parent to F1 models of GvHD, EPO reduced anti-dsDNA autoantibodies, TFH, GC B cells, and clinical expression of kidney disease, while in mice presensitized with BALB/c spleen cells, EPO limited post-transplant increases in DSA following a BALB/c heart transplant, together demonstrating clinical relevance.

*Conclusions: EPO inhibits T cell dependent IgG formation, including DSA by regulating T cell help to B cells. Our data provide support the need for studies testing the hypothesis that EPO treatment prevents DSA formation in human organ transplant recipients.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cantarelli C, Guglielmo C, Bin S, Cumpelik A, Donadei C, Anderson L, Hartzell S, Budge K, Haverly M, Angeletti A, Manna GLa, Fiaccadori E, Maggiore U, Heeger P, Cravedi P. Erythropoietin Reduces Alloantibody Formation by Inhibiting T Follicular Helper Cells [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/erythropoietin-reduces-alloantibody-formation-by-inhibiting-t-follicular-helper-cells/. Accessed May 10, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences